These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 11071880)

  • 1. Less extrahepatic induction of fatty acid beta-oxidation enzymes by PPAR alpha.
    Cook WS; Yeldandi AV; Rao MS; Hashimoto T; Reddy JK
    Biochem Biophys Res Commun; 2000 Nov; 278(1):250-7. PubMed ID: 11071880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
    Peters JM; Zhou YC; Ram PA; Lee SS; Gonzalez FJ; Waxman DJ
    Mol Pharmacol; 1996 Jul; 50(1):67-74. PubMed ID: 8700121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissues of rat.
    Nemali MR; Usuda N; Reddy MK; Oyasu K; Hashimoto T; Osumi T; Rao MS; Reddy JK
    Cancer Res; 1988 Sep; 48(18):5316-24. PubMed ID: 2900680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective effects of chiral clofibric acid analogs on rat peroxisome proliferator-activated receptor alpha (rPPAR alpha) activation and peroxisomal fatty acid beta-oxidation.
    Rangwala SM; O'Brien ML; Tortorella V; Longo A; Loiodice F; Noonan DJ; Feller DR
    Chirality; 1997; 9(1):37-47. PubMed ID: 9094202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression of peroxisome proliferator-activated receptor-alpha may have an important role in the development of non-alcoholic fatty liver disease.
    Yeon JE; Choi KM; Baik SH; Kim KO; Lim HJ; Park KH; Kim JY; Park JJ; Kim JS; Bak YT; Byun KS; Lee CH
    J Gastroenterol Hepatol; 2004 Jul; 19(7):799-804. PubMed ID: 15209628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of potential mechanisms regulating protein expression of hepatic pyruvate dehydrogenase kinase isoforms 2 and 4 by fatty acids and thyroid hormone.
    Holness MJ; Bulmer K; Smith ND; Sugden MC
    Biochem J; 2003 Feb; 369(Pt 3):687-95. PubMed ID: 12435272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.
    Cheung C; Akiyama TE; Ward JM; Nicol CJ; Feigenbaum L; Vinson C; Gonzalez FJ
    Cancer Res; 2004 Jun; 64(11):3849-54. PubMed ID: 15172993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor alpha-responsive genes induced in the newborn but not prenatal liver of peroxisomal fatty acyl-CoA oxidase null mice.
    Cook WS; Jain S; Jia Y; Cao WQ; Yeldandi AV; Reddy JK; Rao MS
    Exp Cell Res; 2001 Aug; 268(1):70-6. PubMed ID: 11461119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator activated receptor-alpha expression in human liver.
    Palmer CN; Hsu MH; Griffin KJ; Raucy JL; Johnson EF
    Mol Pharmacol; 1998 Jan; 53(1):14-22. PubMed ID: 9443928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proteome analysis of livers from obese (ob/ob) mice treated with the peroxisome proliferator WY14,643.
    Edvardsson U; Alexandersson M; Brockenhuus von Löwenhielm H; Nyström AC; Ljung B; Nilsson F; Dahllöf B
    Electrophoresis; 1999; 20(4-5):935-42. PubMed ID: 10344269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver gene expression in rats in response to the peroxisome proliferator-activated receptor-alpha agonist ciprofibrate.
    Yadetie F; Laegreid A; Bakke I; Kusnierczyk W; Komorowski J; Waldum HL; Sandvik AK
    Physiol Genomics; 2003 Sep; 15(1):9-19. PubMed ID: 12851464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver.
    Cariello NF; Romach EH; Colton HM; Ni H; Yoon L; Falls JG; Casey W; Creech D; Anderson SP; Benavides GR; Hoivik DJ; Brown R; Miller RT
    Toxicol Sci; 2005 Nov; 88(1):250-64. PubMed ID: 16081524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisomal-proliferator-activated receptor alpha activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: a key regulation of malonyl-CoA level.
    Lee GY; Kim NH; Zhao ZS; Cha BS; Kim YS
    Biochem J; 2004 Mar; 378(Pt 3):983-90. PubMed ID: 14641110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse regulation of NF-kappaB and peroxisome proliferator-activated receptors in murine nonalcoholic fatty liver.
    Romics L; Kodys K; Dolganiuc A; Graham L; Velayudham A; Mandrekar P; Szabo G
    Hepatology; 2004 Aug; 40(2):376-85. PubMed ID: 15368442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention/reversal of choline deficiency-induced steatohepatitis by a peroxisome proliferator-activated receptor alpha ligand in rats.
    Rao MS; Papreddy K; Musunuri S; Okonkwo A
    In Vivo; 2002; 16(2):145-52. PubMed ID: 12073774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of peroxisome proliferator-activated receptor-alpha in the mechanism underlying changes in renal pyruvate dehydrogenase kinase isoform 4 protein expression in starvation and after refeeding.
    Sugden MC; Bulmer K; Gibbons GF; Holness MJ
    Arch Biochem Biophys; 2001 Nov; 395(2):246-52. PubMed ID: 11697863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes.
    Seo YS; Kim JH; Jo NY; Choi KM; Baik SH; Park JJ; Kim JS; Byun KS; Bak YT; Lee CH; Kim A; Yeon JE
    J Gastroenterol Hepatol; 2008 Jan; 23(1):102-9. PubMed ID: 18171348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for the peroxisomal 3-ketoacyl-CoA thiolase B enzyme in the control of PPARα-mediated upregulation of SREBP-2 target genes in the liver.
    Fidaleo M; Arnauld S; Clémencet MC; Chevillard G; Royer MC; De Bruycker M; Wanders RJ; Athias A; Gresti J; Clouet P; Degrace P; Kersten S; Espeel M; Latruffe N; Nicolas-Francès V; Mandard S
    Biochimie; 2011 May; 93(5):876-91. PubMed ID: 21352884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells.
    Laurora S; Pizzimenti S; Briatore F; Fraioli A; Maggio M; Reffo P; Ferretti C; Dianzani MU; Barrera G
    J Pharmacol Exp Ther; 2003 Jun; 305(3):932-42. PubMed ID: 12649303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of peroxisome proliferator-activated receptor (PPAR)-alpha1 and truncated PPARalpha2 as an adaptive response to fasting in the control of hepatic peroxisomal fatty acid beta-oxidation in the hibernating mammal.
    El Kebbaj Z; Andreoletti P; Mountassif D; Kabine M; Schohn H; Dauça M; Latruffe N; El Kebbaj MS; Cherkaoui-Malki M
    Endocrinology; 2009 Mar; 150(3):1192-201. PubMed ID: 18948393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.